Unlock cutting-edge neuropharmacology with Semax, a synthetic fragment of adrenocorticotropic hormone (ACTH 4-10) that readily crosses the blood–brain barrier and has been shown to elevate brain-derived neurotrophic factor (BDNF) while modulating melanocortin pathways—key mechanisms under investigation for ischemic stroke recovery, cognitive enhancement and mood regulation.
-
Purity: > 99 % (HPLC)
-
Molecular Weight: ≈ 814 Da (C₃₇H₅₁N₉O₁₀S)
-
Form & Sizes: Lyophilized powder in 5 mg and 10 mg research-grade vials
-
Solubility: Sterile water or 0.6 – 0.9 % saline
-
Storage: −20 °C long-term; aliquoted reconstitutions ≤ −80 °C; stable ≤ 24 h at room temperature when protected from light
For laboratory research use only. Not approved for human or veterinary administration. Semax is prescribed clinically only in Russia and Eastern Europe and remains unapproved by the FDA or EMA.